'More Complex and Less Predictable' | GenomeWeb

The ambitious projects being pursued by Verily, Google's life science company, might not be going as well as hoped or promoted, employees and contractors tell Stat News.

The company has been seeking to develop a so-called 'Tricorder' as a diagnostic tool, contact lenses to gauge blood glucose levels in diabetic patients, and embarking on a clinical study called Baseline to define a healthy person, but Stat News reports that these projects have run into problems.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Related Posts

On Their Way Out

'Going Big'

Here's a Spot

For Truth

New Verily Faces

Tech-Transfer Maven

In PLOS this week: role for Notch signaling in congenital heart disease, sciatica risk variants, and more.

Researchers in China have used the CRISPR/Cas9 genome editing approach to alter the length of hair fibers in cashmere goats.

According to ScienceInsider, the Scripps Research Institute and the California Institute for Biomedical Research are merging.

National Cancer Institute researchers didn't report severe adverse events to Food and Drug Administration in a timely manner, the Wall Street Journal reports.